Rexcin Pharmaceuticals Private Limited, a active private limited company, was established on 16 December 2003 in New Delhi, Delhi, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24239DL2003PTC123544. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹2.80 M and a paid-up capital of ₹0.20 M.
It upholds a compliant status. Employing 1 professional, Its leadership includes Satinder Pal Singh (Director), Pradeep Saxena (Director). Past directors included Prem Lata, Narendra Jha, Sanjay Garg. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Flat No. 17-B, First Floor, Block A-1A, Janakpuri, New Delhi, Delhi, 110058.
U24239DL2003PTC123544
123544
16 December 2003
₹2.80 M
₹0.20 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Rexcin Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Satinder Pal Singh | Director | 15 Jul 2015 | Current |
| Pradeep Saxena | Director | 31 Jul 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Jan 2008 | Past |
| Pramod Abcsdd | Director | 13 Jun 2011 | Past |
| Pramod Abcsdd | Additional Director | 17 Mar 2011 | Past |
| Pramod Abcsdd | Additional Director | 01 Jul 2009 | Past |
| Pramod Abcsdd | Additional Director | 28 Sep 2012 | Past |
| Pramod Abcsdd | Additional Director | 01 Jul 2009 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Rexcin Pharmaceuticals Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 37.9% decrease. The company also saw a substantial improvement in profitability, with a 107.51% increase in profit. The company's net worth moved up by a moderate rise of 0.38%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Rexcin Pharmaceuticals had a promoter holding of 100.00%. The company had 1 Subsidiary and 2 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Rexcin Pharmaceuticals has a workforce of 1 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Rexcin Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rexcin Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Rexcin Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Rexcin Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
Satinder Pal Singh was appointed as a Director was appointed as a Director on 15 Jul 2015 & has been associated with this company since 10 years 4 months . was recorded as a recent event.
Progress on Pradeep Saxena was appointed as a Director was appointed as a Director on 31 Jul 2013 & has been associated with this company since 12 years 4 months . was documented.
Progress on Rexcin Pharmaceuticals Private Limited was registered on 16 Dec 2003 with Roc Delhi & aged 21 years 11 months as per MCA records. was documented.
The CIN of Rexcin Pharmaceuticals Private Limited is U24239DL2003PTC123544.
Rexcin Pharmaceuticals Private Limited is headquartered at Flat No. 17-B, First Floor, Block A-1A, Janakpuri, New Delhi, Delhi, 110058.
Rexcin Pharmaceuticals Private Limited was incorporated on 16 December 2003.
The current directors of Rexcin Pharmaceuticals Private Limited are
The primary industry of Rexcin Pharmaceuticals Private Limited is Pharma.
Rexcin Pharmaceuticals Private Limited is unlisted.
The authorized capital of Rexcin Pharmaceuticals Private Limited is ₹2.80 M, and the paid-up capital is ₹0.20 M.
The compliance status of Rexcin Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX